Showing 551-560 of 1782 results for "".
Updates from CSF 2017
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andRhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORCosmeceutical Science
https://practicaldermatology.com/topics/general-topics/cosmeceutical-science/19293/Patti Farris, MD discusses recent developments in cosmeceutical formulation with an emphasis on the latest research on ingredients like botanicals, growth factors, and peptides. She reviews the best evidence for cosmeceuticals and offers tips on product selection and use in a conversation with hostPsoriasis Disparities Among Different Racial and Ethnic Groups
https://practicaldermatology.com/programs/frontlines-psoriasis/psoriasis-disparities-among-different-racial-and-ethnic-groups/24373/Tune in to learn about the disparities that can occur in psoriasis patients with skin of color and how we can optimize their care.Physician Assistants in Dermatology: A Look at the Ethical Considerations
https://practicaldermatology.com/programs/dermconsult/physician-assistants-in-dermatology-a-look-at-the-ethical-considerations/13959/What are the ethical considerations you should keep in mind when utilizing physician assistants in your dermatology practice?Breaking Down BLAST: A Way to Console Displeased Patients
https://practicaldermatology.com/programs/dermconsult/breaking-down-blast-a-way-to-console-displeased-patients/12735/How can we speak with patients who are less than satisfied with their care? These five steps can help.Patients with Psoriasis: Addressing Advocacy and Education Gaps
https://practicaldermatology.com/programs/frontlines-psoriasis/patients-with-psoriasis-addressing-advocacy-and-education-gaps/24372/Why are there are so many gaps in patient education when it comes to psoriasis? Tune in.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatology